Associate Professor Naomi Allen
BSc, MSc, DPhil
Associate Professor in Epidemiology
- Clinical Trial Service Unit
Naomi Allen is an Associate Professor in Epidemiology, based in the Clinical Trial Service Unit and Epidemiological Studies Unit. She has worked predominantly on large-scale prospective studies such as EPIC and the Million Women Study and has a keen research interest in the role of diet, hormones and circulating biomarkers in cancer development. She is co-Principal Investigator of the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group, which aims to conduct individual pooled analyses of the relationship between circulating biomarkers and prostate cancer risk from cohort studies from around the world. In 2011, she became Senior Epidemiologist for UK Biobank and helps co-ordinate record linkage of routine health-related datasets into the study.
Circulating isoflavone and lignan concentrations and prostate cancer risk: A meta-analysis of individual participant data from seven prospective studies including 2828 cases and 5593 controls.
Perez-Cornago A. et al, (2018), Int J Cancer
Mental health in UK Biobank: development, implementation and results from an online questionnaire completed by 157 366 participants
Davis KS. et al, (2018), British Journal of Psychiatry Open, 4, 83 - 90
Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study.
Perez-Cornago A. et al, (2017), Br J Cancer, 117, 1562 - 1571
Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population.
Fry A. et al, (2017), Am J Epidemiol, 186, 1026 - 1034
Anti-Mullerian hormone and endometrial cancer: a multi-cohort study.
Fortner RT. et al, (2017), Br J Cancer, 117, 1412 - 1418